AnaptysBio Inc (ANAB)
19.94
-1.74
(-8.03%)
USD |
NASDAQ |
Nov 04, 16:00
19.67
-0.27
(-1.35%)
After-Hours: 20:00
AnaptysBio Market Cap: 547.34M for Nov. 4, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 01, 2024 | 595.10M |
| October 31, 2024 | 593.73M |
| October 30, 2024 | 608.83M |
| October 29, 2024 | 845.44M |
| October 28, 2024 | 836.93M |
| October 25, 2024 | 879.20M |
| October 24, 2024 | 884.42M |
| October 23, 2024 | 953.86M |
| October 22, 2024 | 964.84M |
| October 21, 2024 | 970.88M |
| October 18, 2024 | 960.18M |
| October 17, 2024 | 965.67M |
| October 16, 2024 | 952.22M |
| October 15, 2024 | 913.24M |
| October 14, 2024 | 953.59M |
| October 11, 2024 | 911.87M |
| October 10, 2024 | 878.38M |
| October 09, 2024 | 862.73M |
| October 08, 2024 | 887.98M |
| October 07, 2024 | 905.83M |
| October 04, 2024 | 932.73M |
| October 03, 2024 | 961.55M |
| October 02, 2024 | 960.73M |
| October 01, 2024 | 955.51M |
| September 30, 2024 | 919.55M |
| Date | Value |
|---|---|
| September 27, 2024 | 874.81M |
| September 26, 2024 | 892.38M |
| September 25, 2024 | 887.71M |
| September 24, 2024 | 957.43M |
| September 23, 2024 | 976.37M |
| September 20, 2024 | 1.056B |
| September 19, 2024 | 1.030B |
| September 18, 2024 | 1.004B |
| September 17, 2024 | 1.029B |
| September 16, 2024 | 1.063B |
| September 13, 2024 | 1.107B |
| September 12, 2024 | 1.051B |
| September 11, 2024 | 977.33M |
| September 10, 2024 | 964.57M |
| September 09, 2024 | 976.51M |
| September 06, 2024 | 985.43M |
| September 05, 2024 | 1.010B |
| September 04, 2024 | 1.019B |
| September 03, 2024 | 990.37M |
| August 30, 2024 | 1.046B |
| August 29, 2024 | 1.005B |
| August 28, 2024 | 1.009B |
| August 27, 2024 | 1.011B |
| August 26, 2024 | 1.024B |
| August 23, 2024 | 1.036B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
276.22M
Minimum
Nov 08 2019
1.107B
Maximum
Sep 13 2024
645.62M
Average
640.15M
Median
Market Cap Benchmarks
| Regeneron Pharmaceuticals Inc | 91.08B |
| Ligand Pharmaceuticals Inc | 2.011B |
| Agios Pharmaceuticals Inc | 2.550B |
| ADMA Biologics Inc | 4.459B |
| Black Diamond Therapeutics Inc | 168.38M |
Market Cap Related Metrics
| PS Ratio | 17.55 |
| PEG Ratio | -0.1405 |
| Price to Book Value | 55.40 |
| Price | 19.94 |
| Earnings Yield | -31.85% |
| PEGY Ratio | -0.1405 |